During the past decade, Clinique Ambroise Paré conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 3 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Ambroise Paré" #1 sponsor was "CMC Ambroise Paré" with 21 trials, followed by "French Cardiology Society" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored and "AfterROSC" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Ambroise Paré" #1 collaborator was "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator, "Agence Regionale de Sante d'Ile de France" with 1 trials as a collaborator, "Assistance Publique Hopitaux De Marseille" with 1 trials as a collaborator, "Biotronik France" with 1 trials as a collaborator and "DePuy Synthes" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Ambroise Paré" are "Heart Failure" (5 trials), "Atrial Fibrillation" (4 trials), "Surgery, Cardiac" (4 trials), "Coronary Artery Disease" (3 trials) and "Acute Coronary Syndrome" (2 trials). Many other conditions were trialed in "Clinique Ambroise Paré" in a lesser frequency.

Most popular intervention types in "Clinique Ambroise Paré" are "Device" (13 trials), "Procedure" (11 trials), "Drug" (8 trials), "Other" (8 trials) and "Diagnostic Test" (5 trials). Other intervention types were less common.

The name of intervention was led by "Administration of the IPREA3 questionnaire" (2 trials), "Immediate feedback through electronic reminder messages" (2 trials), "Ropivacaine" (2 trials), "Targeted interventions in each ICU to reduce discomforts" (2 trials) and "1 year follow-up to assess psychiatric morbidity" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Ambroise Paré" are 48 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Ambroise Paré". undefined are not yet recruiting, 10 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Clinique Ambroise Paré, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Ambroise Paré, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 20 trials that are defined as “Not Applicable".